{
  "resourceType" : "CodeSystem",
  "id" : "TreatmentRegimen",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem TreatmentRegimen</b></p><a name=\"TreatmentRegimen\"> </a><a name=\"hcTreatmentRegimen\"> </a><a name=\"TreatmentRegimen-en-US\"> </a><p>This case-insensitive code system <code>https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">toplusfem<a name=\"TreatmentRegimen-toplusfem\"> </a></td><td>2+5 eller lign, eks. CT</td><td>2+5 eller lign, eks. CT</td></tr><tr><td style=\"white-space:nowrap\">aida<a name=\"TreatmentRegimen-aida\"> </a></td><td>AIDA</td><td>AIDA</td></tr><tr><td style=\"white-space:nowrap\">all_ved<a name=\"TreatmentRegimen-all_ved\"> </a></td><td>ALL vedligehold</td><td>ALL vedligehold</td></tr><tr><td style=\"white-space:nowrap\">atoatra<a name=\"TreatmentRegimen-atoatra\"> </a></td><td>ATO+ATRA</td><td>ATO+ATRA</td></tr><tr><td style=\"white-space:nowrap\">azacitidinmono<a name=\"TreatmentRegimen-azacitidinmono\"> </a></td><td>Azacitidin monoterapi</td><td>Azacitidin monoterapi</td></tr><tr><td style=\"white-space:nowrap\">azacitidinvene<a name=\"TreatmentRegimen-azacitidinvene\"> </a></td><td>Azacitidin-venetoclax</td><td>Azacitidin-venetoclax</td></tr><tr><td style=\"white-space:nowrap\">hydrea<a name=\"TreatmentRegimen-hydrea\"> </a></td><td>Hydrea</td><td>Hydrea</td></tr><tr><td style=\"white-space:nowrap\">hdara_c<a name=\"TreatmentRegimen-hdara_c\"> </a></td><td>Hd-Ara-c +- supplement</td><td>Hd-Ara-c +- supplement</td></tr><tr><td style=\"white-space:nowrap\">ade<a name=\"TreatmentRegimen-ade\"> </a></td><td>ADE +- supplement</td><td>ADE +- supplement</td></tr><tr><td style=\"white-space:nowrap\">da<a name=\"TreatmentRegimen-da\"> </a></td><td>DA +- supplement</td><td>DA +- supplement</td></tr><tr><td style=\"white-space:nowrap\">da31087<a name=\"TreatmentRegimen-da31087\"> </a></td><td>DA inkl. 3+10, 3+8, 3+7</td><td>DA inkl. 3+10, 3+8, 3+7</td></tr><tr><td style=\"white-space:nowrap\">da31087my<a name=\"TreatmentRegimen-da31087my\"> </a></td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td><td>DA inkl. 3+10, 3+8, 3+7 + mylotarg</td></tr><tr><td style=\"white-space:nowrap\">da31087mi<a name=\"TreatmentRegimen-da31087mi\"> </a></td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td><td>DA inkl. 3+10, 3+8, 3+7 + midostaurin</td></tr><tr><td style=\"white-space:nowrap\">flag<a name=\"TreatmentRegimen-flag\"> </a></td><td>FLAG +- supplement</td><td>FLAG +- supplement</td></tr><tr><td style=\"white-space:nowrap\">flagmito<a name=\"TreatmentRegimen-flagmito\"> </a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG</td></tr><tr><td style=\"white-space:nowrap\">flagmitovene<a name=\"TreatmentRegimen-flagmitovene\"> </a></td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td><td>FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax</td></tr><tr><td style=\"white-space:nowrap\">gilteritinib<a name=\"TreatmentRegimen-gilteritinib\"> </a></td><td>Gilteritinib</td><td>Gilteritinib</td></tr><tr><td style=\"white-space:nowrap\">idarac<a name=\"TreatmentRegimen-idarac\"> </a></td><td>IdAraC</td><td>IdAraC</td></tr><tr><td style=\"white-space:nowrap\">inotuzumab<a name=\"TreatmentRegimen-inotuzumab\"> </a></td><td>Inotuzumab ozogamicin</td><td>Inotuzumab ozogamicin</td></tr><tr><td style=\"white-space:nowrap\">mace<a name=\"TreatmentRegimen-mace\"> </a></td><td>MACE +- supplement</td><td>MACE +- supplement</td></tr><tr><td style=\"white-space:nowrap\">midac<a name=\"TreatmentRegimen-midac\"> </a></td><td>MidAC</td><td>MidAC</td></tr><tr><td style=\"white-space:nowrap\">midostaurin_ved<a name=\"TreatmentRegimen-midostaurin_ved\"> </a></td><td>Midostaurin vedligehold</td><td>Midostaurin vedligehold</td></tr><tr><td style=\"white-space:nowrap\">ldara<a name=\"TreatmentRegimen-ldara\"> </a></td><td>LdARA-C +- supplement</td><td>LdARA-C +- supplement</td></tr><tr><td style=\"white-space:nowrap\">atra<a name=\"TreatmentRegimen-atra\"> </a></td><td>ATRA</td><td>ATRA</td></tr><tr><td style=\"white-space:nowrap\">apl_mt<a name=\"TreatmentRegimen-apl_mt\"> </a></td><td>APL-vedligeholdsbehandling</td><td>APL-vedligeholdsbehandling</td></tr><tr><td style=\"white-space:nowrap\">azacytidin_supplement<a name=\"TreatmentRegimen-azacytidin_supplement\"> </a></td><td>5-Azacytidin +- supplement</td><td>5-Azacytidin +- supplement</td></tr><tr><td style=\"white-space:nowrap\">blinatumomab<a name=\"TreatmentRegimen-blinatumomab\"> </a></td><td>Blinatumomab</td><td>Blinatumomab</td></tr><tr><td style=\"white-space:nowrap\">vyxeos<a name=\"TreatmentRegimen-vyxeos\"> </a></td><td>Vyxeos +- supplement</td><td>Vyxeos +- supplement</td></tr><tr><td style=\"white-space:nowrap\">nopho_2008<a name=\"TreatmentRegimen-nopho_2008\"> </a></td><td>NOPHO-2008</td><td>NOPHO-2008</td></tr><tr><td style=\"white-space:nowrap\">all_mt<a name=\"TreatmentRegimen-all_mt\"> </a></td><td>ALL vedligeholdelsesbehandling</td><td>ALL vedligeholdelsesbehandling</td></tr><tr><td style=\"white-space:nowrap\">other_ikke<a name=\"TreatmentRegimen-other_ikke\"> </a></td><td>Anden ikke-intensiv</td><td>Anden ikke-intensiv</td></tr><tr><td style=\"white-space:nowrap\">other_eks<a name=\"TreatmentRegimen-other_eks\"> </a></td><td>Anden eksperimentel</td><td>Anden eksperimentel</td></tr><tr><td style=\"white-space:nowrap\">other_semi<a name=\"TreatmentRegimen-other_semi\"> </a></td><td>Anden semiintensiv (f.eks. Plan B)</td><td>Anden semiintensiv (f.eks. Plan B)</td></tr><tr><td style=\"white-space:nowrap\">other_int<a name=\"TreatmentRegimen-other_int\"> </a></td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td><td>Anden intensiv (f.eks. BISHOP, Plan A)</td></tr><tr><td style=\"white-space:nowrap\">hyper_cvad<a name=\"TreatmentRegimen-hyper_cvad\"> </a></td><td>Hyper-CVAD</td><td>Hyper-CVAD</td></tr><tr><td style=\"white-space:nowrap\">alltogether_mt<a name=\"TreatmentRegimen-alltogether_mt\"> </a></td><td>ALLtogether</td><td>ALLtogether</td></tr><tr><td style=\"white-space:nowrap\">experimental<a name=\"TreatmentRegimen-experimental\"> </a></td><td>anden behl incl anden experimentel</td><td>anden behl incl anden experimentel</td></tr></table></div>"
  },
  "url" : "https://kip.rkkp.dk/fhir/CodeSystem/TreatmentRegimen",
  "version" : "0.2.1",
  "name" : "TreatmentRegimen",
  "title" : "Treatment regimen",
  "status" : "active",
  "date" : "2022-07-12T00:00:00+02:00",
  "publisher" : "Sundhedsvæsnets Kvalistetsinstitut with Trifork Digital Health A/S",
  "contact" : [{
    "name" : "Sundhedsvæsnets Kvalistetsinstitut with Trifork Digital Health A/S",
    "telecom" : [{
      "system" : "url",
      "value" : "https://trifork.com"
    },
    {
      "system" : "email",
      "value" : "rbk@trifork.com"
    }]
  }],
  "description" : "Treatment regimen",
  "caseSensitive" : false,
  "content" : "complete",
  "count" : 37,
  "concept" : [{
    "code" : "toplusfem",
    "display" : "2+5 eller lign, eks. CT",
    "definition" : "2+5 eller lign, eks. CT"
  },
  {
    "code" : "aida",
    "display" : "AIDA",
    "definition" : "AIDA"
  },
  {
    "code" : "all_ved",
    "display" : "ALL vedligehold",
    "definition" : "ALL vedligehold"
  },
  {
    "code" : "atoatra",
    "display" : "ATO+ATRA",
    "definition" : "ATO+ATRA"
  },
  {
    "code" : "azacitidinmono",
    "display" : "Azacitidin monoterapi",
    "definition" : "Azacitidin monoterapi"
  },
  {
    "code" : "azacitidinvene",
    "display" : "Azacitidin-venetoclax",
    "definition" : "Azacitidin-venetoclax"
  },
  {
    "code" : "hydrea",
    "display" : "Hydrea",
    "definition" : "Hydrea"
  },
  {
    "code" : "hdara_c",
    "display" : "Hd-Ara-c +- supplement",
    "definition" : "Hd-Ara-c +- supplement"
  },
  {
    "code" : "ade",
    "display" : "ADE +- supplement",
    "definition" : "ADE +- supplement"
  },
  {
    "code" : "da",
    "display" : "DA +- supplement",
    "definition" : "DA +- supplement"
  },
  {
    "code" : "da31087",
    "display" : "DA inkl. 3+10, 3+8, 3+7",
    "definition" : "DA inkl. 3+10, 3+8, 3+7"
  },
  {
    "code" : "da31087my",
    "display" : "DA inkl. 3+10, 3+8, 3+7 + mylotarg",
    "definition" : "DA inkl. 3+10, 3+8, 3+7 + mylotarg"
  },
  {
    "code" : "da31087mi",
    "display" : "DA inkl. 3+10, 3+8, 3+7 + midostaurin",
    "definition" : "DA inkl. 3+10, 3+8, 3+7 + midostaurin"
  },
  {
    "code" : "flag",
    "display" : "FLAG +- supplement",
    "definition" : "FLAG +- supplement"
  },
  {
    "code" : "flagmito",
    "display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG",
    "definition" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG"
  },
  {
    "code" : "flagmitovene",
    "display" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax",
    "definition" : "FLAG-Ida eller lign inkl FLAG, Mito-FLAG + venetoclax"
  },
  {
    "code" : "gilteritinib",
    "display" : "Gilteritinib",
    "definition" : "Gilteritinib"
  },
  {
    "code" : "idarac",
    "display" : "IdAraC",
    "definition" : "IdAraC"
  },
  {
    "code" : "inotuzumab",
    "display" : "Inotuzumab ozogamicin",
    "definition" : "Inotuzumab ozogamicin"
  },
  {
    "code" : "mace",
    "display" : "MACE +- supplement",
    "definition" : "MACE +- supplement"
  },
  {
    "code" : "midac",
    "display" : "MidAC",
    "definition" : "MidAC"
  },
  {
    "code" : "midostaurin_ved",
    "display" : "Midostaurin vedligehold",
    "definition" : "Midostaurin vedligehold"
  },
  {
    "code" : "ldara",
    "display" : "LdARA-C +- supplement",
    "definition" : "LdARA-C +- supplement"
  },
  {
    "code" : "atra",
    "display" : "ATRA",
    "definition" : "ATRA"
  },
  {
    "code" : "apl_mt",
    "display" : "APL-vedligeholdsbehandling",
    "definition" : "APL-vedligeholdsbehandling"
  },
  {
    "code" : "azacytidin_supplement",
    "display" : "5-Azacytidin +- supplement",
    "definition" : "5-Azacytidin +- supplement"
  },
  {
    "code" : "blinatumomab",
    "display" : "Blinatumomab",
    "definition" : "Blinatumomab"
  },
  {
    "code" : "vyxeos",
    "display" : "Vyxeos +- supplement",
    "definition" : "Vyxeos +- supplement"
  },
  {
    "code" : "nopho_2008",
    "display" : "NOPHO-2008",
    "definition" : "NOPHO-2008"
  },
  {
    "code" : "all_mt",
    "display" : "ALL vedligeholdelsesbehandling",
    "definition" : "ALL vedligeholdelsesbehandling"
  },
  {
    "code" : "other_ikke",
    "display" : "Anden ikke-intensiv",
    "definition" : "Anden ikke-intensiv"
  },
  {
    "code" : "other_eks",
    "display" : "Anden eksperimentel",
    "definition" : "Anden eksperimentel"
  },
  {
    "code" : "other_semi",
    "display" : "Anden semiintensiv (f.eks. Plan B)",
    "definition" : "Anden semiintensiv (f.eks. Plan B)"
  },
  {
    "code" : "other_int",
    "display" : "Anden intensiv (f.eks. BISHOP, Plan A)",
    "definition" : "Anden intensiv (f.eks. BISHOP, Plan A)"
  },
  {
    "code" : "hyper_cvad",
    "display" : "Hyper-CVAD",
    "definition" : "Hyper-CVAD"
  },
  {
    "code" : "alltogether_mt",
    "display" : "ALLtogether",
    "definition" : "ALLtogether"
  },
  {
    "code" : "experimental",
    "display" : "anden behl incl anden experimentel",
    "definition" : "anden behl incl anden experimentel"
  }]
}